Coya Therapeutics Highlights Strategic Vision Under New CEO, With Key 2025 Milestones Including ALS Trial With Dr. Reddy's Partnership Worth Up To $700M, Emerging Opportunities In Parkinson's And Autoimmune Conditions, And Focus On Non-Dilutive...
Coya Therapeutics Highlights Strategic Vision Under New CEO, With Key 2025 Milestones Including ALS Trial With Dr. Reddy's Partnership Worth Up To $700M, Emerging Opportunities In Parkinson's And Autoimmune Conditions, And Focus On Non-Dilutive...
Coya Therapeutics在新任CEO的領導下強調了其戰略願景，2025年的關鍵里程碑包括與Dr. Reddy's的合作進行ALS試驗，價值高達70000萬美元，正在出現的帕金森病和自身免疫疾病的機會，以及專注於非稀釋性......
Coya Therapeutics Highlights Strategic Vision Under New CEO, With Key 2025 Milestones Including ALS Trial With Dr. Reddy's Partnership Worth Up To $700M, Emerging Opportunities In Parkinson's And Autoimmune Conditions, And Focus On Non-Dilutive Funding To Advance Treg-Enhancing Biologics For Neurodegenerative And Autoimmune Diseases
Coya Therapeutics強調了新任首席執行官領導下的戰略願景，2025年的關鍵里程碑包括與雷迪博士合作的價值高達7億美元的ALS試驗，帕金森氏症和自身免疫性疾病的新機遇，以及專注於非稀釋性資金以推進神經退行性和自身免疫性疾病的Treg增強生物製劑
Dear Fellow Stockholder,
尊敬的各位股東，
Given my recent transition to the role of CEO, I wanted to share my thoughts on Coya and our future and to express my gratitude to our founder and Executive Chair, Dr. Howard Berman, whose bold vision has instilled the "innovation and get-it-done" culture in Coya's DNA. We...
鑑於我最近轉任首席執行官一職，我想分享我對Coya和我們未來的看法，並對我們的創始人兼執行主席霍華德·...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間